Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.195 USD | +2.14% | -10.69% | +11.43% |
05-07 | Transcript : Aclaris Therapeutics, Inc., Q1 2024 Earnings Call, May 07, 2024 | |
05-07 | Earnings Flash (ACRS) ACLARIS THERAPEUTICS Reports Q1 Revenue $2.4M, vs. Street Est of $2M | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.43% | 83.38M | |
+23.28% | 44.96B | |
+0.40% | 42.65B | |
+46.00% | 41.85B | |
-5.31% | 29.04B | |
+10.92% | 26.08B | |
-21.03% | 19.03B | |
+6.34% | 12.75B | |
+29.11% | 12.06B | |
-3.53% | 11.75B |
- Stock Market
- Equities
- ACRS Stock
- News Aclaris Therapeutics, Inc.
- Stifel Nicolaus Initiates Coverage on Aclaris Therapeutics With Buy Rating, $29 Price Target